This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2no3

From Proteopedia

Revision as of 20:54, 12 November 2007 by OCA (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search

2no3, resolution 3.20Å

Drag the structure with the mouse to rotate

Novel 4-anilinopyrimidines as potent JNK1 Inhibitors

Contents

Overview

A new series of 4-anilinopyrimidines has been synthesized and evaluated as, JNK1 inhibitors. SAR studies led to the discovery of potent JNK1, inhibitors with good enzymatic activity as well as cellular potency, represented by compound 2b. Kinase selectivity profile and the crystal, structure of 2b are also described.

Disease

Known disease associated with this structure: Diabetes mellitus, noninsulin-dependent OMIM:[604641]

About this Structure

2NO3 is a Single protein structure of sequence from Homo sapiens with SO4 and 859 as ligands. Active as Mitogen-activated protein kinase, with EC number 2.7.11.24 Full crystallographic information is available from OCA.

Reference

Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: Synthesis and SAR studies., Liu M, Wang S, Clampit JE, Gum RJ, Haasch DL, Rondinone CM, Trevillyan JM, Abad-Zapatero C, Fry EH, Sham HL, Liu G, Bioorg Med Chem Lett. 2007 Feb 1;17(3):668-72. Epub 2006 Nov 2. PMID:17107797

Page seeded by OCA on Mon Nov 12 23:00:32 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools